CS
Christoph Samuel Ziegler bought $33K of VRXA stock
Christoph Samuel Ziegler, Dir of Veraxa Biotech AG (VRXA), bought 30,000 shares of VRXA stock worth $33K, per an SEC Form 4 filed Oct 21, 2026.
It was an open-market purchase.
The trade happened on Oct 20, 2026, 1 day before it was made public.
VRXA has moved +2.0% since the trade date, from $1.01 to $1.03 (Nov 19, 2026 close).
- Traded
- Oct 20, 2026
- Disclosed
- Oct 21, 2026
- Filing delay
- 1 day
- Price since
- +2.0%
- Role
- Dir
- Source
- SEC Form 4